SCHEMBL2454166

SCHEMBL2454166

CC1(O)OC(=O)C(c2cccs2)=C1c1ccc(Cl)cc1

nearest known ligand 0.72

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 18/20 0.72
PTGS1 P23219 5/20 0.46
EDNRA P25101 1/20 0.37
LPL P06858 1/20 0.36
LIPG Q9Y5X9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4607900 0.81 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL2456618 0.79 PTGS2 (0.72) PTGS2PTGS1EDNRA
SCHEMBL4583796 0.79 PTGS2 (0.52) PTGS2PTGS1
SCHEMBL4583198 0.76 PTGS2 (0.52) PTGS2PTGS1LPLLIPG
SCHEMBL4582575 0.75 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL2350613 0.75 PTGS2 (0.60) PTGS2PTGS1
SCHEMBL7842927 0.74 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL2356409 0.74 PTGS2 (0.58) PTGS2PTGS1
SCHEMBL3974343 0.74 PTGS2 (0.58) PTGS2PTGS1EDNRA
SCHEMBL2348407 0.73 PTGS2 (0.57) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1958948-B1 PYRIDAZINE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2011-10-05 EP disclosed
US-8022073-B2 Substituted pyridazine compounds and fungicidal uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-20 US disclosed
US-8022073-B2 Substituted pyridazine compounds and fungicidal uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-20 US disclosed
US-8022073-B2 Substituted pyridazine compounds and fungicidal uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-20 US disclosed
US-20090156608-A1 Pyridazine Compound and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-18 US disclosed
US-20090156608-A1 Pyridazine Compound and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-18 US disclosed
US-20090156608-A1 Pyridazine Compound and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-18 US disclosed
EP-1974608-A1 Arylpyridazines as fungicides Bayer CropScience AG (DE) 2008-10-01 EP disclosed
EP-1974608-A1 Arylpyridazines as fungicides Bayer CropScience AG (DE) 2008-10-01 EP disclosed
EP-1958948-A1 PYRIDAZINE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-08-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156608-A1 Pyridazine Compound and Use Thereof PLPBP, PNPO, PDXK PTGS2 577/4885PTGS1 1335/4885EDNRA 3260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.